![Allan Wehnert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Wehnert
Nessuna posizione attualmente
Health Technology
Profilo
Allan Wehnert is the founder of Orocidin AS, established in 2023, and holds the title of Chief Executive Officer.
Former jobs include VP-R&D Project Strategy & Portfolio Management at H.
Lundbeck A and Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A.
Posizioni attive di Allan Wehnert
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Allan Wehnert
| Società | Posizione | Fine |
|---|---|---|
| INITIATOR PHARMA A/S | Direttore Tecnico/Scientifico/R&S | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
